Sign up to save your podcasts
Or
Share Understanding Blood-Based Biomarkers in Alzheimer Disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Understanding Blood-Based Biomarkers in Alzheimer Disease
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
279279 ratings
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
133 Listeners
NEJM This Week
314 Listeners
Practical Neurology Podcast
48 Listeners
JAMA Clinical Reviews
492 Listeners
The Curbsiders Internal Medicine Podcast
3,325 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,116 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
191 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
365 Listeners
Continuum Audio
79 Listeners